Clinical trialNCT01685229CompletedObservational

Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis

SponsorIntegra LifeSciences CorporationEnrollment198Sinusitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Boris Karanfilov, MD
Ohio Sinus Institute
Principal Investigator
clinicaltrials.gov ↗
Christopher Melroy, MD
Georgia Nasal and Sinus Institute
Principal Investigator
clinicaltrials.gov ↗
Spencer Payne, MD
University of Virginia
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Denver, Colorado, United States
Facility name not stated
Miami, Florida, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Atlanta, Georgia, United States
Facility name not stated
Savannah, Georgia, United States
Facility name not stated
Vidalia, Georgia, United States
Facility name not stated
Chicago, Illinois, United States
Facility name not stated
Rockford, Illinois, United States
Facility name not stated
South Bend, Indiana, United States
Facility name not stated
Louisville, Kentucky, United States
Facility name not stated
Neptune City, New Jersey, United States
Facility name not stated
Dublin, Ohio, United States
Facility name not stated
Frisco, Texas, United States
Facility name not stated
McKinney, Texas, United States
Facility name not stated
Plano, Texas, United States
Facility name not stated
Charlottesville, Virginia, United States
Facility name not stated
Norfolk, Virginia, United States
Facility name not stated
Richmond, Virginia, United States
Facility name not stated
Beaver Dam, Wisconsin, United States
Facility name not stated
Wauwatosa, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Medical Management

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Sept 2012
Primary completion: 1 Apr 2015
Completion: 1 Aug 2015
Last update posted: 12 Jul 2024
Registered enrollment: 198
Registry id: NCT01685229

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.